The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Orthomax sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Orthomax is a supplier of orthodontic products. The company supplies adhesives, arch wires and wires, bands, brackets and bondable attachments, buccal tubes, clearance specials, and elastomeric products. Orthomax supplies products from Tomy International, PSM Medical Solutions, G&H Orthodontics, and Ixion Instrument. Orthomax is headquartered in Bennettswood, Victoria, Australia.
The key metrics of Orthomax related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Orthomax is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Orthomax.
For a detailed understanding of the performance of Orthomax, buy the report here.